Hazard
66 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 66 subpotent recalls we have scored against our rubric, 2 (3%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 8 (12%) are Severe.
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all subpotent recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
CAREone Earwax Removal Drops (Carbamide Peroxide 6.5%) are recalled because the product contains significantly reduced active ingredient (~0.6% vs. expected ~6–7%) and low pH, making it ineffective.
Vasopressin 2 Units/2 mL in 0.9% sodium chloride syringes from IntegraDose Compounding Services are being recalled as a subpotent drug. 287 units are affected.
Remedy Gel, hydrocortisone 1%, distributed by glo Skin Beauty is being recalled because the product is subpotent. The action covers 1,060 bottles.
Avantor Performance Materials is recalling one lot of bulk Magnesium Chloride 6-Hydrate active pharmaceutical ingredient because the material is subpotent. 36 bottles are affected.
Skin Rehab Calming Skin Gel Hydrocortisone Balm, hydrocortisone 1%, is being recalled because the product is subpotent. The action covers 2,895 bottles.
Essential Calming Skin Gel containing 1% hydrocortisone is being recalled because the product is subpotent. The action covers 299 bottles.
Teva is recalling three lots of Isotretinoin Capsules, USP, 30 mg because the product was found to be superpotent and subpotent. 21,984 packages are affected.
Teva is recalling three lots of Isotretinoin Capsules, USP, 40 mg because the product was found to be superpotent and subpotent. 8,376 packages are affected.
Macleods Pharma USA is recalling one lot of Levothyroxine Sodium Tablets USP 150 mcg because the product is subpotent.
Specialty Process Labs is recalling one lot of Thyroid, USP bulk drug substance because it is subpotent.
Zydus Pharmaceuticals is recalling 22,896 bottles of Icosapent Ethyl capsules, 1 gram, because oxidation caused by leakage of the capsule contents has left them subpotent.
Somerset Therapeutics is recalling 28,660 vials of Cisatracurium Besylate Injection, 200mg/20mL, after out of specification assay results during long term stability testing.
Somerset Therapeutics is recalling 52,340 vials of Cisatracurium Besylate Injection, 10 mg/5 mL, after out of specification assay results during long term stability testing.
Somerset Therapeutics is recalling 71,310 vials of Cisatracurium Besylate Injection, 20 mg/10 mL, after out of specification assay results during long term stability testing.
Dr. Reddy's Laboratories is recalling 4,800 bottles of Varenicline Tablets, 1mg, after the assay value for the affected lot fell below the specification limit at nine-month stability testing.
Medline is recalling 222,800 alcohol prep pads from one lot because the product is subpotent.
IntegraDose Compounding Services is recalling 853 bags of Oxytocin 30 Units/500 mL in 0.9% sodium chloride after testing revealed there was no oxytocin in the IV bag.
Accord Healthcare is recalling 54,432 bottles of Levothyroxine Sodium Tablets USP 88 mcg after long-term stability testing found assay content below the approved specification range.
Levoxyl (levothyroxine sodium tablets, USP) 50 mcg from Pfizer is being recalled because the product is subpotent. 29,004 bottles are affected.
Epinephrine Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL vials compounded by Imprimis NJOF are being recalled because of subpotent assay results during stability testing. 6,880 vials affected.
A compounded Tropicamide-Proparacaine-Phenylephrine-Ketorolac sterile ophthalmic solution is being recalled because of subpotent assay results during stability testing. 2,890 vials are affected.
Levothyroxine Sodium Tablets, USP 100 mcg from Accord Healthcare are being recalled because the product is subpotent, with an assay below the approved specification. 9,739 bottles affected.
Levothyroxine Sodium Tablets, USP 25 mcg in 1000-count bottles from Accord Healthcare are being recalled because the product is subpotent. 2,352 bottles are affected.
Levothyroxine Sodium Tablets, USP 50 mcg from Accord Healthcare are being recalled because the product is subpotent, with an assay below the approved specification. 54,227 bottles affected.
Levothyroxine Sodium Tablets, USP 175 mcg from Accord Healthcare are being recalled because the product is subpotent, with an assay below the approved specification. 2,344 bottles affected.